| Vifor Fresenius Medical Care Renal Pharma Ltd. - Tavneos 10 mg, Hartkapseln | | 66772 | | 01 | | Tavneos 10 mg | | Hartkapseln | | L04AJ05 | | | | 19.09.2022 | | |
| | Composition | | avacopanum 10 mg, macrogolglyceroli hydroxystearas 245 mg, macrogolum 4000, Kapselhülle: E 172 (rubrum), E 172 (flavum), E 171, gelatina, polysorbatum 80, Drucktinte: E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Avacopanum | 10 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Avacopanum | 10 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | E 171 | | color. | | E 172 | | Drucktinte | | Gelatina | | | | Macrogolglyceroli Hydroxystearas | 245 mg | | | Macrogol | 4000 | | | Polysorbatum 80 | | | | Pro Capsula | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | DDP | DDP | B | | Oui | | 002 | 180 | 5442.02 | 5891.30 | B | LS | Oui |
|
|
